Celltrion Healthcare seals $886m IPO at top end

Celltrion Healthcare has bagged W1tr ($886.3m) after pricing its IPO at the top of the initial marketing range, according to a banker familiar with the matter.

  • By Jonathan Breen
  • 17 Jul 2017

Having launched its transaction on July 3, the marketing arm of South Korean drug maker Celltrion closed books in Asia last Friday, July 14, and in the US and Europe on Saturday. They were heavily oversubscribed across the board, according to the banker.

The float comprised 24.6m primary ...

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.

Panda Bonds Top Arrangers

Rank Arranger Share % by Volume
1 Bank of China (BOC) 28.15
2 CITIC Securities 21.52
3 China CITIC Bank Corp 9.93
4 China Merchants Bank Co 9.38
5 Industrial and Commercial Bank of China (ICBC) 7.73

Bookrunners of Asia-Pac (ex-Japan) ECM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 CITIC Securities 13,827.70 78 5.91%
2 UBS 13,644.76 81 5.84%
3 Goldman Sachs 10,607.81 53 4.54%
4 Morgan Stanley 10,186.93 54 4.36%
5 China Securities Co Ltd 9,861.82 46 4.22%

Bookrunners of Asia Pacific (ex-Japan) G3 DCM

Rank Lead Manager Amount $m No of issues Share %
  • Last updated
  • Today
1 HSBC 31,937.38 214 8.21%
2 Citi 30,315.32 183 7.79%
3 JPMorgan 23,972.21 138 6.16%
4 Bank of America Merrill Lynch 20,455.99 106 5.26%
5 Standard Chartered Bank 16,084.80 122 4.13%

Asian polls & awards